Support Tool for Families of High-Risk Children With Heart Disease During Hospital Admission and After Discharge

NCT05926661 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-09-19

No results posted yet for this study

Summary

The goal of this study is to pilot the "support tool" in the Nemours Cardiac Center to assess acceptability and feasibility. This tool will be offered to 5 high-risk families, and they will be asked to complete a survey. In addition, healthcare providers including bed-side nurses and cardiologists will be asked to complete a survey to assess the feasibility of the tool.

Conditions

  • Heart Disease Congenital

Interventions

OTHER

NCC Support Toolkit

Pre-discharge intervention- * Set expectations for parents/caregivers to spend time bedside and attend rounds * iPad for the families to use the Nemours App, download education materials and Facetime communication with medical personnel. * Download Nemours App and teach them how to use it * Education materials- to ease the use of medications, Oxygen and feeding * Assistance with transportation, child care, parental work schedule for discharge teaching Post Discharge intervention (Day 1-2): • Video/Facetime call with the family to check equipment, home environment and answer questions about medications and formula Post discharge intervention (Day 3-7): • Phone call to the family to ensure transportation for their first follow-up appointment, answer questions about medications, Oxygen and feeding.

Sponsors & Collaborators

  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH
  • Nemours Children's Clinic

    lead OTHER

Principal Investigators

  • Deepika Thacker, MD · Nemours Children's Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-29
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05926661 on ClinicalTrials.gov